These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 28922348)

  • 1. Stem cell biology and regenerative medicine for neonatal lung diseases.
    Kang M; Thébaud B
    Pediatr Res; 2018 Jan; 83(1-2):291-297. PubMed ID: 28922348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translating Basic Research into Safe and Effective Cell-based Treatments for Respiratory Diseases.
    Ikonomou L; Wagner DE; Turner L; Weiss DJ
    Ann Am Thorac Soc; 2019 Jun; 16(6):657-668. PubMed ID: 30917290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell therapies for neonatal lung diseases: Are we there yet?
    Thébaud B
    Semin Perinatol; 2023 Apr; 47(3):151724. PubMed ID: 36967368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concise review: current status of stem cells and regenerative medicine in lung biology and diseases.
    Weiss DJ
    Stem Cells; 2014 Jan; 32(1):16-25. PubMed ID: 23959715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-based therapies for neonatal lung disease.
    O'Reilly M; Thébaud B
    Cell Tissue Res; 2017 Mar; 367(3):737-745. PubMed ID: 27770256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchopulmonary Dysplasia: Where Have All the Stem Cells Gone?: Origin and (Potential) Function of Resident Lung Stem Cells.
    Möbius MA; Thébaud B
    Chest; 2017 Nov; 152(5):1043-1052. PubMed ID: 28479114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Good things come in small packages": application of exosome-based therapeutics in neonatal lung injury.
    Willis GR; Mitsialis SA; Kourembanas S
    Pediatr Res; 2018 Jan; 83(1-2):298-307. PubMed ID: 28985201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchopulmonary Dysplasia and Chronic Lung Disease: Stem Cell Therapy.
    Pierro M; Ciarmoli E; Thébaud B
    Clin Perinatol; 2015 Dec; 42(4):889-910. PubMed ID: 26593085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stromal Cell Therapy for Respiratory Complications of Extreme Prematurity.
    Thébaud B
    Am J Perinatol; 2018 May; 35(6):566-569. PubMed ID: 29694998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Potential of Endothelial Progenitor Cells in Pulmonary Diseases.
    Kolesnichenko OA; Whitsett JA; Kalin TV; Kalinichenko VV
    Am J Respir Cell Mol Biol; 2021 Nov; 65(5):473-488. PubMed ID: 34293272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The promise of stem cells in bronchopulmonary dysplasia.
    O'Reilly M; Thébaud B
    Semin Perinatol; 2013 Apr; 37(2):79-84. PubMed ID: 23582961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells in the pathogenesis and treatment of bronchopulmonary dysplasia: a clinical review.
    Simones AA; Beisang DJ; Panoskaltsis-Mortari A; Roberts KD
    Pediatr Res; 2018 Jan; 83(1-2):308-317. PubMed ID: 28945702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell therapy for bronchopulmonary dysplasia: bench to bedside translation.
    Ahn SY; Chang YS; Park WS
    J Korean Med Sci; 2015 May; 30(5):509-13. PubMed ID: 25931779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the future of clinical trials and translation of mesenchymal stromal cell therapies for neonatal disorders.
    Chang YS; Yang M; Ahn SY; Sung SI; Park WS
    Stem Cells Transl Med; 2024 Oct; 13(10):941-948. PubMed ID: 39120439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells for the prevention of neonatal lung disease.
    O'Reilly M; Thébaud B
    Neonatology; 2015; 107(4):360-4. PubMed ID: 26044105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung Progenitor and Stem Cell Transplantation as a Potential Regenerative Therapy for Lung Diseases.
    Serna Villa V; Ren X
    Transplantation; 2024 Oct; 108(10):e282-e291. PubMed ID: 38416452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When Is an Alveolar Type 2 Cell an Alveolar Type 2 Cell? A Conundrum for Lung Stem Cell Biology and Regenerative Medicine.
    Beers MF; Moodley Y
    Am J Respir Cell Mol Biol; 2017 Jul; 57(1):18-27. PubMed ID: 28326803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cells and regenerative medicine in lung biology and diseases.
    Lau AN; Goodwin M; Kim CF; Weiss DJ
    Mol Ther; 2012 Jun; 20(6):1116-30. PubMed ID: 22395528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amnion-derived cells as a reliable resource for next-generation regenerative medicine.
    Umezawa A; Hasegawa A; Inoue M; Tanuma-Takahashi A; Kajiwara K; Makino H; Chikazawa E; Okamoto A
    Placenta; 2019 Sep; 84():50-56. PubMed ID: 31272680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.
    Sammour I; Somashekar S; Huang J; Batlahally S; Breton M; Valasaki K; Khan A; Wu S; Young KC
    PLoS One; 2016; 11(10):e0164269. PubMed ID: 27711256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.